Investigating molecular assays for cancer epidemiology
Official title: DCEG- Molecular Assays for epidemiology studies
Funded at Leidos Biomedical Research, INC. · NIH-11219748 · Data updated 2026-11-12
This study is looking at how to better understand cancer by analyzing blood and cervical samples from patients, using advanced technology to check for mutations and immune responses, which can help improve cancer prevention and treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project start | September 28, 2024 |
| Project end | August 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $721,598 |
| NIH project number | 75N91019D00024-0-759102400011-6 |
| Project ID | NIH-11219748 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals with cervical cancer or those at risk for virus-related tumors who are willing to provide biological samples.
✕Less likely to help
Patients with non-cancerous conditions or those not related to the study's focus on cervical cancer and virus-related tumors may not receive any benefit.
What this research studies
This research focuses on the extraction and processing of DNA and other biological specimens to support cancer epidemiology studies. It utilizes advanced mass spectrometry techniques to analyze protein biomolecules and offers clinical diagnostics for mutation detection and pathogen analysis. The project also examines immunological factors related to cervical cancer, providing insights into the immune response to virus-related tumors. Patients' biological samples, such as blood and cervical specimens, will be processed and analyzed to enhance understanding of cancer development and prevention.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic methods and better understanding of cancer mechanisms, ultimately benefiting patient care and treatment strategies.
How similar studies have gone: Previous research has shown success in using molecular assays and mass spectrometry for cancer diagnostics, indicating a promising approach in this area.
Where this research is happening
-
Leidos Biomedical Research, INC.
Frederick, United States Active
Researchers
- Principal investigator: Briscoe, Lynn — Leidos Biomedical Research, INC.
- Study coordinator: Briscoe, Lynn
Related research
Other NIH-funded projects on the same topics.
-
Improving public health responses to COVID-19 through standardized testing.
This study is looking to improve how we fight COVID-19 by testing blood samples to see if people have had the virus, and it’s designed for anyone interested in better ways to manage the disease.
-
Creating a large library of cancer models for research use
This study is creating a collection of new cancer models to help researchers and companies find better ways to treat cancer, making it easier for everyone to work together and share ideas.
-
Advancing global cancer control through data analysis and international collaboration
This study is all about helping countries around the world work better together to fight cancer by sharing important information and training scientists, especially in places that need extra support.
-
Support for HIV and HPV cancer prevention clinical trials in the Americas
This study is working on new vaccines and treatments to help prevent cancers related to HIV and HPV, making sure that patients in the US, Latin America, and the Caribbean can access better options as these exciting trials move forward.
-
Development and production of clinical-grade biopharmaceuticals
This study is all about making safe and effective new medicines, like vaccines and treatments for various conditions, so that patients can have access to the latest therapies that meet high-quality standards.
-
Understanding the immune response to COVID-19
This study is looking for ways to improve COVID-19 testing and understand how our immune system fights the virus, and you can help by sharing samples to make these tests better for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.